Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Gross Margin: 2019-2025

Historic Gross Margin for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to 100.00%.

  • Kymera Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Kymera Therapeutics' Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Gross Margin high stood at 100.00% for Q1 2021, and its period low was 100.00% during Q1 2021.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 100.00%.